Navigation Links
BioStorage Technologies Serves as Repository for Landmark Study of Coronary Artery Disease

INDIANAPOLIS, July 23 /PRNewswire/ -- BioStorage Technologies, Inc. (BST) will serve as the biorepository partner for the first phase of the Indiana Health Study, a new landmark longitudinal study of coronary artery disease. This community-based research initiative will utilize the population of Indianapolis and surrounding areas as study participants and will enable research that will lead to new drugs and diagnostics that allow doctors to better manage common, chronic diseases such as heart disease, cancer and diabetes.

Sponsored by the Fairbanks Institute for Healthy Communities, an Indianapolis-based nonprofit organization, the Indiana Health Study will create one of the nation's most comprehensive resources for academic and commercial research by integrating biological samples, medical data and lifestyle information collected from two cohorts of people: patients with coronary artery disease and people without the disease.

The collected biological samples will be stored at BST's state-of-the-art facility located in Indianapolis. "We selected BioStorage because of their expertise in cold chain logistics, sample management and long term storage, which are all necessities for a study of this scope and importance," said Dr. Cynthia Helphingstine, president and COO of the Fairbanks Institute. "We are fortunate to have partnered with a company that shares our strong commitment for community-based life science research."

Dr. John F. Mills, M.D., Ph.D., chief executive officer of BioStorage Technologies believes the Indiana Health Study can make a significant impact on the future of health care for people in Indiana and around the world. "We believe we can play a vital role in advancing health care and research initiatives through ensuring sample integrity. In a study of this magnitude samples are vital and could possibly hold the key to unlocking the causes of some of this nation's deadliest diseases."

While the Indiana Health Study will follow participants for years, Helphingstine anticipates immediate benefits as well. Samples will be available for researchers as soon as they are collected. The Fairbanks Institute intends to study multiple chronic diseases with future research platforms including studies on cancer, diabetes and central nervous system disorders.

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is a leader in sample storage, inventory management and coldchain logistics for the biotechnology and pharmaceutical industries. The company offers secure, temperature-controlled storage; real-time tracking of stored biological samples; and next-day return of biomaterials. BioStorage Technologies is privately-held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit or call +1 (866) 697-2675 or +49-6155-898-1010.

About Fairbanks Institute

Formed with a $10 million gift from the Richard M. Fairbanks Foundation and the collaboration of BioCrossroads, Indiana University School of Medicine, Regenstrief Institute and other Indianapolis community health leaders, Fairbanks Institute is creating one of the nation's most comprehensive resources for finding better ways to prevent, diagnose and treat the nation's most common, chronic diseases.

Press Contact:

Whitney Dean

Miller Brooks, Inc.


SOURCE BioStorage Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioStorage Technologies Announces Platinum Sponsorship of Biorepositories 2008
2. BioStorage Technologies Forms Scientific Advisory Board with Leading Life Science Experts
3. BioStorage Technologies Appoints Dr. Wolfgang Hoffer as Managing Director of European Operations
4. BioStorage Technologies Appoints Lori Ball as Vice President
5. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
6. Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period
7. MacroGenics Acquires Raven Biotechnologies
8. Netsmart Technologies Web Seminar Helps Behavioral Health Organizations Understand Electronic Prescribing and the Importance of New Medicare-Related E-Prescribing Legislation
9. FDA Grants Epeius Biotechnologies Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
10. Epeius Biotechnologies Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma
11. Senesco Technologies Closes Remaining $3.0 Million of Previously Announced Financing
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... be speaking at the following conference, and invited investors ... York, NY      Tuesday, December 1, 2015 at ... York, NY      Tuesday, December 1, 2015 at ... Healthcare Conference, New York, NY ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... on behalf of the Toronto Stock Exchange, confirms that ... are no corporate developments that would cause the recent ... --> --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical ...
(Date:11/24/2015)... SHPG ) announced today that Jeff Poulton , ... Annual Healthcare Conference in New York City ... (1:30 p.m. GMT). --> SHPG ) announced today that ... Piper Jaffray 27 th Annual Healthcare Conference in ... at 8:30 a.m. EST (1:30 p.m. GMT). --> Shire ...
(Date:11/24/2015)... ... November 24, 2015 , ... In harsh industrial ... points for in-line sensors can represent a weak spot where leaking process media ... of retractable sensor housings , which are designed to tolerate extreme process conditions. ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has ... of MIT and Harvard for use of its ... information management tools. The partnership will support the ... biological and chemical research information internally and with ... be used for managing the Institute,s electronic laboratory ...
(Date:11/10/2015)... 2015  In this report, the biomarkers ... product, type, application, disease indication, and geography. ... are consumables, services, software. The type segments ... efficacy biomarkers, and validation biomarkers. The applications ... development, drug discovery and development, personalized medicine, ...
(Date:11/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), ... broader entry into the automotive market with a comprehensive ... pace of consumer electronics human interface innovation. Synaptics, industry-leading ... for the automotive industry and will be implemented in ... Europe , Japan , and ...
Breaking Biology News(10 mins):